Emcure Pharma shares have risen 4.07% in the last 12 months and 0.26% year-to-date. (Photo: Envato) Show Quick Read Summary is AI Generated. Newsroom Reviewed

Emcure Pharmaceuticals Ltd. and Novo Nordisk India had partnered to launch a weight loss injection in India, the company announced on Monday. The collaboration will strengthen the distribution and marketing of Poviztra, semaglutide injection 2.4 mg for weight loss, particularly through pharmacies and in regions beyond those currently served by Novo Nordisk India.

Poviztra is a second brand of Wegovy. Wegovy (semaglutide injection 2.4 mg) was launched in India in June 2025. It is indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management and reduction in the risk of major adv

See Full Page